Page 2 - Germany Based Morphosys News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Germany based morphosys. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Germany Based Morphosys Today - Breaking & Trending Today

German biotech company MorphoSys buys US rival for $1.7B

BERLIN (AP) Germany-based MorphoSys AG said Wednesday that it is buying U.S. rival. ....

United Kingdom , Constellation Pharmaceuticals Inc , Germany Based Morphosys , Constellation Pharmaceuticals , Royalty Pharma , Western Europe , Bob Berlin , B Germany , Constellation Pharmaceuticals Inc , C Complete State National , Urope News , A Wire , Usiness Stories , Ews Health Stories , Op News , Usiness News , F Wire , Hoice Plus , Royalty Pharma , ஒன்றுபட்டது கிஂக்டம் , விண்மீன் மருந்துகள் இன்க் , விண்மீன் மருந்துகள் , ராயல்டி பார்மா , ெசிதேர்ந் யூரோப் , ஓப் செய்தி , எஃப் கம்பி ,

MorphoSys to buy Constellation Pharma in a $1.7B bet on epigenetic cancer drugs

MedCity News
MorphoSys to buy Constellation Pharma in a $1.7B bet on epigenetic cancer drugs
MorphoSys is acquiring Constellation Pharmaceuticals and its late-stage myelofibrosis drug in a deal that values the epigenetics biotech at $1.7 billion. Germany-based MorphoSys will finance the acquisition with cash from a separate $2 billion deal with drug royalty acquirer Royalty Pharma.
Shares0

MorphoSys, a biotech that has spent much of its three-decade history developing drugs that ended up at other companies via partnerships or licensing deals, is now building up its own pipeline through a $1.7 billion acquisition of Constellation Pharmaceuticals.
Constellation will bring to MorphoSys clinical-stage drugs and expertise in epigenetics, the study of turning genes on or off without altering the genetic code. That research has yielded a Phase 3 drug candidate for a rare blood cancer, as well as another compound in mid-stage testing with the potential to brin ....

United States , United Kingdom , Constellation Pharmaceuticals , Germany Based Morphosys , Massachusetts Based Constellation , Cambridge Based Elizma , Malte Peters , Morphosys Chief Financial Officer Sung Lee , Royalty Pharma , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Healthcare It , Foodborne Pathogens , Iagnostics Company , Iagnostic Platforms , Minimally Invasive Surgery ,